Frequency of Neonatal Hyperglycemia at Assuit University Children Hospital
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
- 主要终点
- 1-Detection of prevalence of neonatal hyperglycemia by estimating RBG level in serum 2-Assessment of risk factors, clinical characteristics and possible complications of neonatal hyperglycemia.
研究概览
简要总结
Detection of prevalence of neonatal hyperglycemia and assessment of risk factors, clinical characteristics and possible complications of neonatal hyperglycemia.
详细描述
Hyperglycemia has become an important risk factor for mortality and morbidity in the neonatal period, especially with increased survival rates of very low birth weight neonates.
Neonatal hyperglycemia is usually defined as serum glucose greater than 150 mg/dl (8.3 mmol/L) or whole blood glucose greater than 125 mg/dl (6.9 mmol/L) irrespective of gestational or postmenstrual age. Usually, the safe target for a neonate's serum glucose level is 70 to 150 mg/dl. The cut off for safe target is based on the renal glucose threshold of preterm neonates.
Hyperglycemia is more common in preterm infants than term infants as it occurs in one-third of preterm and small gestational age (SGA) infants and is generally noted during the first week of life. Usually, the acute hyperglycemia resolves over two to three days in most neonates but can last up to ten days. Hyperglycemia is less common than hypoglycemia among neonates but is associated with increased mortality and morbidity among neonates. Neonatal hyperglycemia is inversely related to birth weight and gestational age.
Glucose is an essential source of energy for the fetus and neonate. The brain growth of the fetus exclusively depends upon glucose. In the early postnatal period, glucose homeostasis occurs via glycogenolysis and gluconeogenesis. The critical regulatory mechanisms of glucose homeostasis are sluggish in the initial days, particularly among preterm neonates. The mechanisms of neonatal hyperglycemia are multifactorial. The risk of hyperglycemia increases with the severity of the accompanying illness. The most common cause is high exogenous glucose infusion rates (GIR) in preterm infants who are already at risk for hyperglycemia due to the following reasons,
- decreased ability to suppress endogenous glucose production,
- decreased insulin response to glucose, and
- limited glycogen and fat stores. Hyperglycemia in the neonatal period develops as a result of other multiple risk factors including.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 28 Days(Child)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •all neonates from day 0 to 28 days old admitted in NICU.
排除标准
- •> 28 days old
结局指标
主要结局
1-Detection of prevalence of neonatal hyperglycemia by estimating RBG level in serum 2-Assessment of risk factors, clinical characteristics and possible complications of neonatal hyperglycemia.
时间窗: 1-11-2024
assesment how many children diagnosed with neonatal hyperglycemia . what are risk factors those cause this problem . what are the manifestationsof neonatal hyperglycemia and possible complications of neonatal hyperglycemia
次要结局
未报告次要终点
研究者
Hend Rashad abdeltawab
doctor
Assiut University
